2007

Morgner, A., Schmelz, R., Thiede, C., Stolte, M. & Miehlke, S. (2007) Therapy of gastric mucosa associated lymphoid tissue lymphoma. World J Gastroenterol, 13, 3554-3566.

Bornhauser, M., Mohr, B., Oelschlaegel, U., Bornhauser, P., Jacki, S., Ehninger, G. & Thiede, C. (2007) Concurrent JAK2(V617F) mutation and BCR-ABL translocation within committed myeloid progenitors in myelofibrosis. Leukemia, 21, 1824-1826.

Dransfeld, C.L., Schaich, M., Ho, A.D., Thiede, C., Ehninger, G. & Mahlknecht, U. (2007) Class I HDAC SNP analysis in healthy donors compared to AML patients. Leukemia, 21, 1587-1590.

Illmer, T., Thiede, H.M., Thiede, C., Bornhauser, M., Schaich, M., Schleyer, E. & Ehninger, G. (2007) A highly sensitive method for the detection of PKC412 (CGP41251) and its metabolites by high-performance liquid chromatography. J Pharmacol Toxicol Methods, 56, 23-27.

Bornhauser, M., Illmer, T., Schaich, M., Soucek, S., Ehninger, G. & Thiede, C. (2007) Improved outcome after stem-cell transplantation in FLT3/ITD-positive AML. Blood, 109, 2264-2265; author reply 2265.

Illmer, T., Schaich, M., Ehninger, G. & Thiede, C. (2007) Tyrosine kinase mutations of JAK2 are rare events in AML but influence prognosis of patients with CBF-leukemias. Haematologica, 92, 137-138.

Thiede, C., Creutzig, E., Reinhardt, D., Ehninger, G. & Creutzig, U. (2007) Different types of NPM1 mutations in children and adults: evidence for an effect of patient age on the prevalence of the TCTG-tandem duplication in NPM1-exon 12. Leukemia, 21, 366-367.